ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹12,965 Cr | ₹12,668 Cr | ₹11,599 Cr | ₹10,634 Cr | ₹8,865 Cr |
What is the latest Revenue of ALKEM LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹12,965 Cr |
| Mar2025 | ₹12,668 Cr |
| Mar2024 | ₹11,599 Cr |
| Mar2023 | ₹10,634 Cr |
| Mar2022 | ₹8,865 Cr |
How is Revenue of ALKEM LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,965 Cr | 2.34 | |
| Mar2025 | ₹12,668 Cr | 9.21 | |
| Mar2024 | ₹11,599 Cr | 9.08 | |
| Mar2023 | ₹10,634 Cr | 19.96 | |
| Mar2022 | ₹8,865 Cr | - | |
Compare Revenue of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹62,311.6 Cr | -2% | -5.3% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -2% |
-5.3% |
-1.4% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses